These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 802567)

  • 21. Effective nasal influenza vaccine delivery using chitosan.
    Read RC; Naylor SC; Potter CW; Bond J; Jabbal-Gill I; Fisher A; Illum L; Jennings R
    Vaccine; 2005 Aug; 23(35):4367-74. PubMed ID: 15916838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the therapeutic action of anti-influenza gamma-globulins obtained by donor vaccination with live and killed vaccines].
    Galkina MV; Volkova VA
    Vopr Okhr Materin Det; 1979 Dec; 24(12):16-9. PubMed ID: 93345
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and efficacy of influenza vaccine in children.
    Goldstein LG
    Ann Pharmacother; 2003 Nov; 37(11):1712-5. PubMed ID: 14565808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasoflu - a live influenza vaccine.
    Drug Ther Bull; 1976 Jan; 14(1):3-4. PubMed ID: 1245145
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of an attenuated, live, bivalent, influenza vaccine in children.
    Burech DL; Koranyi KI; Haynes RE
    Ohio State Med J; 1976 Jul; 72(7):385-7. PubMed ID: 934582
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characteristics of the reactogenic and immunogenic properties of killed influence vaccine purified and concentrated by the method of adsorbed chromatography on silicate sorbents].
    Peradze TV; Fridman EA; Kolikov VM; Bichurina MA; Goriunova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):18-22. PubMed ID: 1015075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Improvement of the preparation of anti-influenza donor gamma-globulin. Report 1. Experience in the cultivation of the killed influenza vaccine, purified and concentrated by means of gradient centrifugation].
    Sokolov NN; Zhukova TIa; Malafeeva LK; Geft RA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():74-7. PubMed ID: 4143404
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ways to increase the effectiveness of the immunoprophylaxis of influenza among the troops].
    Perepelkin VS; Spirande VV
    Voen Med Zh; 1979 Feb; (2):39-42. PubMed ID: 377794
    [No Abstract]   [Full Text] [Related]  

  • 31. [Secretory immunity in persons inoculated with killed influenza vaccine purified and concentrated on silicate sorbents].
    Bichurina MA
    Tr Inst Im Pastera; 1976; 47():134-40. PubMed ID: 210539
    [No Abstract]   [Full Text] [Related]  

  • 32. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Postgrad Med J; 1973 Mar; 49(569):152-8. PubMed ID: 4802501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FluMist: an intranasal live influenza vaccine.
    Med Lett Drugs Ther; 2003 Aug; 45(1163):65-6. PubMed ID: 12915803
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combined prevention of influenza using inactivated influenza vaccine and remantadine in organized collectives of adults].
    Malysheva AM; Ignat'eva GS; Erofeeva MK; Efremov BV; Maksakova VL
    Tr Inst Im Pastera; 1982; 57():16-20. PubMed ID: 6221444
    [No Abstract]   [Full Text] [Related]  

  • 36. Secretory immune response after nasal vaccination with live attenuated influenza viruses.
    Crifö S; Vella S; Filiaci F; Resta S; Rocchi G
    Rhinology; 1980 Jun; 18(2):87-92. PubMed ID: 7403787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Improvement of the preparation of anti-influenza donor gamma globulin. Report 2. Testing of the immunogenicity of the killed vaccine, purified and concentrated by means of gradient centrifugation].
    Malafeeva LK; Fridman EA; Tentser PS; Geft RA; Sokolov NN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():78-83. PubMed ID: 4143405
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental data concerning an influenza vaccine prepared with a B type strain.
    Petrescu A; Mihail A
    Rev Roum Virol (1972); 1974; 25(3):231-3. PubMed ID: 4465901
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.
    Rudenko LG; Lonskaya NI; Klimov AI; Vasilieva RI; Ramirez A
    Bull World Health Organ; 1996; 74(1):77-84. PubMed ID: 8653819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.